Light-mediated in cell downregulation of G-quadruplex-containing genes using a photo-caged ligand

Pierre Murat1, Michael V Gormally, Debbie Sanders

  • 1Department of Chemistry, The University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. sb10031@cam.ac.uk.

Chemical Communications (Cambridge, England)
|August 17, 2013
PubMed

Insights

A novel caged G-quadruplex ligand enables UV-controlled gene regulation. This method significantly downregulates the SRC oncogene, crucial for epithelial tumor growth, offering a new therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Cancer Research

Background:

  • G-quadruplex structures are non-canonical DNA secondary structures found in gene promoter regions.
  • Transcriptional control of oncogenes is a key target for cancer therapy.
  • Targeting oncogenes like SRC is important for treating epithelial tumors.

Purpose of the Study:

  • To develop a method for external control of gene transcription using a caged G-quadruplex ligand.
  • To investigate the effect of this method on the expression of the SRC oncogene.

Main Methods:

  • Utilized a caged G-quadruplex ligand that releases the active ligand upon UV light exposure.
  • Applied the caged ligand and UV treatment to cells containing quadruplex-forming genes.
  • Quantified the expression levels of the SRC oncogene post-treatment.

Main Results:

  • The caged G-quadruplex ligand, activated by UV light, effectively controlled gene transcription.
  • Significant downregulation of the SRC oncogene was observed in treated cells.
  • This synergistic effect of the ligand and UV light highlights a novel regulatory mechanism.

Conclusions:

  • Caged G-quadruplex ligands offer a precise, externally triggered method for gene regulation.
  • This approach demonstrates potential for targeted downregulation of oncogenes like SRC.
  • The findings open new avenues for photodynamic cancer therapy strategies.